<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN">
<html><body style='font-size: 10pt; font-family: Verdana,Geneva,sans-serif'>
<p>Certainly.</p>
<p>Human cutaneous infections with L. braziliensis are known for the low parasite load. Amastigotes are hard to find in cutaneous lesions due to L. braziliensis.</p>
<p>Regards,</p>
<p>Sergio C. F. Mendonça MD, PhD<br /> Senior Scientist<br /> Head, Laboratory of Immunoparasitology<br /> Instituto Oswaldo Cruz<br /> Rio de Janeiro, RJ, Brazil<br /> Phone +55 21 3865 8199</p>
<p> </p>
<div> </div>
<p>Em 02/04/2015 21:16, Flavio Queiroz Telles escreveu:</p>
<blockquote type="cite" style="padding-left:5px; border-left:#1010ff 2px solid; margin-left:5px"><!-- html ignored --><!-- head ignored --><!-- meta ignored -->
<div>Dear All</div>
<div>I have a patient who presented proved cutaneous leishmaniasis 3 years ago. He was successfully treated with meglumine but after 3 years he presented a secondary auricular lesion. Biopsy did not show amastigotes but histology like leishmaniasis (no parasites). Anew meglumine course was effective. Considering L. braziliensis braziliensis is the only species identified in the state of Parana, South of Brazil, is this feasible?</div>
<div> </div>
<div>Regards</div>
<div> </div>
<div>Flavio Queiroz telles MD, PhD</div>
<div>Federal University of Parana, Brazil</div>
<div> </div>
<br /><br />--<br /><em> This email was sent by icb.usp.br </em> ­­ <!-- html ignored --><br />
<pre>_______________________________________________
Leish-l mailing list
<a href="mailto:Leish-l@lineu.icb.usp.br">Leish-l@lineu.icb.usp.br</a>
<a href="http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l">http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l</a>
--
This email was sent by icb.usp.br
</pre>
</blockquote>
</body></html>